-
2021-02-26
JOINN was Successfully Listed on the Hong Kong Stock Exchange
... -
2020-04-03
JOINN’s Clinical Team Participated in the Clinical Trials of Highlypathogenic Coronavirus N Protein
... -
2020-03-18
A Milestone has been Reached in the Development of COVID-19 Vaccines
... -
2020-02-16
JOINN's Analysis and Clinical Team Went to Wuhan to help with Novel Coronavirus New Drug R&D
...